Please login to the form below

Not currently logged in

Quality in Care Hepatitis C programme open for entry

QiC Hepatitis C NHS TaysidePMGroup's QiC programme aims to recognise best practice in care for hepatitis C in the UK

BMS gives Erbitux rights to Lilly in the US

Erbitux - Merck KGaAFirm wants to focus on its burgeoning PD-1 cancer range

First generic version of Teva’s Copaxone cleared by FDA

Teva CopaxoneWill be marketed as Glatopa by Momenta and Novartis’ Sandoz subsidiary

Pfizer breast cancer drug shines in latest trial

Pfizer headquartersStudy with Ibrance stopped early because of its success

France health reforms draw opposition from doctors

France flagDoctors claim the changes will leave them out of pocket

The CementBloc adds new creative leadership team

The CementBloc Marc LawRobin Tzannes, Sharon Howard-Butler and Marc Law join the US comms agency

AstraZeneca gains FDA orphan status for new cancer drug

AstraZeneca AZ headquarters London UKGains a longer patent life for the investigational lung disease drug

Health apps won't change behaviour, says professor

healthcare industry appsNew op-ed argues that many applications have not been tested or approved by a regulator

Mission Critical

When it’s lonely at the top, leaders can seek a critical friend

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

Connections are crucial to continued improvements in healthcare. Together, by connecting and sharing our collective knowledge and experience, we can...

Latest intelligence

Rise of generics will curb France’s pharma growth
Generics are set to take a serious bite out of the market as a cash-strapped government pushes for cost controls...
How to account for different motivations in closed loop marketing
While your CLM technology might be brand new, the communications strategy behind should be tried and tested. In fact one of the earliest exponents of rhetoric, Aristotle, can still inform...
Framing, provocation, and truth
It all depends on how you ask the question…...